Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alder biopharmaceutical
allergan
american academy of neurology
amgen
atogepant
biohaven
biotech
bob azelby
boston blog main
boston top stories
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
clinical trials
detroit blog main
detroit top stories
drugs
eli lilly
eptinezumab
erenumab
fda
fremanezumab
galcanezumab
impel neuropharma
indiana blog main
indiana top stories
jefferies
lasmiditan
life sciences
marc goodman
medical device
migraine
migraine research foundation
morphine
national
national blog main
national top stories
new york blog main
What
class
3
×
drug
3
×
year
3
×
companies
new
abuse
agency
amgen
approval
arguments
big
called
commercialized
competitors
concern
conducted
crippling
cut
days
dea
decades
demand
drugs
enforcement
erenumab
extra
fda
fewer
growing
headaches
late
led
lot
make
manufactured
means
medication
medications
meeting
migraine
Language
Current search:
class
×
drug
×
year
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@theverge.com
7 years ago
This new drug promises fewer days a month with migraines
@theverge.com
7 years ago
The DEA just cut opioid production by 25 percent for next year
